RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
31 hedge funds and large institutions have $24.8M invested in Regulus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
15% more funds holding
Funds holding: 27 → 31 (+4)
0.72% more ownership
Funds ownership: 2.18% → 2.9% (+0.72%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
31
Holding in Top 10
1
Calls
$92K
Puts
$34K
Top Buyers
| 1 | +$3.23M | |
| 2 | +$2.36M | |
| 3 | +$1.18M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$367K |
| 5 |
Renaissance Technologies
New York
|
+$330K |
Top Sellers
| 1 | -$56K | |
| 2 | -$36K | |
| 3 | -$21.6K | |
| 4 |
BlackRock
New York
|
-$11K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$9K |